Sign in

CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
850642577
Phone
650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,410
in 2 filings

Net −$5,410. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-07-21 Pons Jaume President and CEO Conversion · Series C Convertible Preferred Stock −5,264 0
2020-07-16 Adelman Robert J 10% owner Conversion · Series C Convertible Preferred Stock −1,052,950 0
2020-07-16 Graham G. Walmsley Director Grant or award · Stock Option (right to buy) +24,009 24,009
2020-07-16 Nielsen Jack Director Grant or award · Stock Option (right to buy) +24,009 24,009
2020-07-16 Lettmann Jason Director Grant or award · Stock Option (right to buy) +24,009 24,009
2020-07-16 GOODMAN COREY S Director Grant or award · Stock Option (right to buy) +24,009 24,009
2020-07-16 Randolph Sophia Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +89,657 89,657
2020-07-16 Pietzke Steffen VP Fin & Chief Acct Officer Grant or award · Employee Stock Option (right to buy) +41,789 41,789
2020-07-16 GARCIA PETER S Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +88,137 88,137
2020-07-16 Caffo Nathan Chief Business Officer Grant or award · Employee Stock Option (right to buy) +22,794 22,794
2020-07-16 Pons Jaume President &CEO Grant or award · Employee Stock Option (right to buy) +272,771 272,771
2020-05-03 Pinto Shelly VP, Finance and CAO Grant or award · Employee Stock Option (right to buy) +125,000 125,000

Page 22 of 22 · 432 trades